Israel’s Medical Device & HealthCare IT Industry
Israel at the Medica November 2019
Vardina Hilloo

For many years, Israeli medicine has been considered as one of the highest among developed countries,
advanced diagnostics in Israel is applied  in the laboratory of the future and experience the most innovative
techniques and excellent lectures at MEDICA 2019 in Duesseldorf city. The visitors could have had Discove
r the most innovative laboratory medical techniques. The Israeli Pavilion, as every year, has become a
pilgrimage center for visitors to the thirsty exhibition for Israeli news in the fields of medicine, development
and science, and it is buzzing with life from morning to evening on all four days.
By the end of the 1990s, Israel was home to more than 200 life science companies. With steady growth
over the last decade (some 40 new companies formed each year), Israel has introduced creativity and
innovation into the field; today there are over 1500 active companies.

The Largest Sectors is Medical Devices and Digital Health (over 65 percent of companies). In the medical
device arena, Israeli scientists and engineers have integrated advanced technologies in electronics,
communications and electro-optics to develop world-class innovations in Digital Imaging, Medical Lasers,
Telemedicine, Early Diagnostics, Smart Surgical Equipment and more.

Over 600 medical device exporters engaged in a variety of medical application such as Cardiovascular and
Peripheral Vascular, Neurology and Degenerative Diseases, Preparedness and Emergency Medicine,
Intensive Care, Women Health, Orthopedics and Sport Medicine, Gastrointestinal, Infection Control,
Ophthalmology, Pain and Wound Management, Oral and Dental Care, Dermatology and Aesthetics.

The digital era opens tremendous opportunities to deliver healthcare services to patients at the comfort
of their homes or wherever they are, through any web or mobile device, without requiring a presence
of healthcare provider in the loop. For millions of people that live in distance from or in scarcity of
healthcare resources and services, the growing spread of smartphones creates new possibilities to
improve healthcare services access and quality of life. Telemedicine, mHealth, Wearables, Remote Monitoring,
Electronic Medical Records, Big Data Analytics, Internet of Medical Things, Medical Apps and others
all can be incorporate into Digital Health or Health Information Technologies.

Israeli Digital Health industry has its roots in a long history of using innovative communication technologies
to improve healthcare delivery. With more than 25 years of expertise in implementing health IT, electronic
medical records and Big Data Analytics; today, our Government keeps investing strongly in IT thus putting
Israeli expertise in international demand Lauded as a “startup nation,” Israel has always been at th
e forefront of innovation and research. It comes as no surprise that the country was crowned the
10th most innovative in the Global Innovation Index 2019.
The magazine NoCamels reported that, Israel has been steadily climbing the ladder of the index, rising 11
spots in the last four years. Entrepreneurship is indeed in the country’s DNA: in 2019, rates of entrepreneurial
activity in Israel were about 13 percent amongst working-age adults, compared to rates of six percent in
Germany, seven percent in Switzerland and eight percent in the UK. The Index, which uses 80 different
indicators to assess the innovation performance of 129 countries, has become an authoritative benchmarking
tool for policy-makers, entrepreneurial leaders and global decision-makers creating private-public ties,
this year, the report is themed around medical and the future of healthcare, a domain where Israel is a world leader.

At the Medica we were exposed to interesting and innovative companies in the field of healing, such as
“B-Cure Laser” a break-through Innovation in the laser technology, a Patented mobile Medical device
presented by an International company in the fields of: Pain Management - orthopaedic conditions -
musculoskeletal conditions with the devices “Classic” and “Sport” Wounds Inc. hard to heal -diabetic
ulcers pressure. A Systematic literature supports the outstanding efficacy of B-Cure Laser vs all medica
l Photomedicine devices for Home use worldwide for the treatment of pain and wound healing.
The efficacy of the different models is supported by a great double blind clinical trials
results. All models have CE mark.
“Cnoga Medical” company is an non-invasive Medical Devices for Outpatient Monitoring and Diabetes
Management Cnoga medical is a leading global company for outpatient monitoring. CNOGA is a privately
held international company, founded in 2004, with headquarters in Israel and subsidiaries in China and Brazil.
CNOGA researches and develops innovative technologies in the field of non-invasive medical devices.

MedCu Technologies is the world’s first and only Copper wound dressing provider that got the CE certificate and
FDA clearance for marketing. The copper wound dressing is impregnated with copper particles. This pioneering
implementation of copper properties has been developed in over 15 years of intensive research and is
protected by over 30 patents.

neoLaser A World Leader in Endovascular and Proctology Lasers NeoLaser designs, manufactures and distributes
medical laser products, offering top-notch quality and design, providing superb performance and functionality,
flexibility and modularity, all at an affordable cost. The company is ISO13485 certified, holds CE mark,
FDA, TGA, Health Canada, and Anvisa clearance for its high-end medical laser systems.

Nucleix develop, manufacture and market non-invasive cancer tests Nucleix Ltd. develops, manufactures and
markets highly innovative and non-invasive molecular cancer diagnostic tests. Our highly sensitive and specific
tests are based on identification of subtle changes in methylation patterns. Nucleix technology is based on
a combination of a new biochemical platform in conjunction with sophisticated algorithms.

Pulsehaler™ – Breakthrough Treatment for COPD Respinova has developed a new device for the treatment
of COPD. COPD is the 3rd most fatal of all diseases affecting over 350 million people worldwide.
Respinova’s Pulsehaler™ technology is the first and only treatment to directly open the small airways,
thereby reducing breathlessness and improving patient’s ability.

Tel Aviv University and the Technion made it to the list of Worldwide Top-100 Universities Granted US Utility Patents
in 2018. In addition to their academic achievements, these universities consider their impact on the marketplace
as a key metric of success. This change in perspective in the aims of academic research is the first step in creating
the ideal innovation environment. Israel has built a network of 15 Technology Transfer Offices (TTOs) attached to
research hubs, acting as a middleman between researchers and business investors, offering useful commercial
expertise to bring the lab to the marketplace. When it comes to medical technology transfer, Israel looks beyond
universities alone: six of the 15 TTOs in Israel are attached to hospitals and health maintenance organizations.
Several of these have generated over US $10 billion in sales each.
While this approach is useful, it is essential to involve more entrepreneurs, investors and commercial entities
into the research ecosystem in order to successfully take tomorrow’s innovations to the market.